Bénédicte M J Merle1, Rachel E Silver1, Bernard Rosner2, Johanna M Seddon3. 1. Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, MA; 2. Channing Division of Network Medicine, Harvard Medical School, Harvard University, Boston, MA. 3. Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, MA; jseddon@tuftsmedicalcenter.org.
Abstract
BACKGROUND: Adherence to a Mediterranean-type diet is linked to a lower risk of mortality and chronic disease, but the association with the progression of age-related macular degeneration (AMD) and genetic susceptibility is unknown. OBJECTIVE: We examined the association of adherence to the Mediterranean diet and genetic susceptibility with progression to advanced AMD. DESIGN: Among 2525 subjects in the AREDS (Age-Related Eye Disease Study), 1028 eyes progressed to advanced AMD over 13 y. Baseline data for demographic and behavioral covariates were collected by using questionnaires. Dietary data were collected from food-frequency questionnaires. The alternate Mediterranean diet (aMeDi) score (range: 0-9) was constructed from individual intakes of vegetables, fruit, legumes, whole grains, nuts, fish, red and processed meats, alcohol, and the ratio of monounsaturated to saturated fats. Ten genetic loci in 7 genes [complement factor H (CFH), age-related maculopathy susceptibility 2/high-temperature requirement A serine peptidase 1 (ARMS2/HTRA1), complement component 2 (C2), complement factor B (CFB), complement component 3 (C3), collagen type VIII α 1 (COL8A1), and RAD51 paralog B (RAD51B)] were examined. Survival analysis was used to assess individual eyes for associations between incident AMD and aMeDi score, as well as interaction effects between aMeDi score and genetic variation on risk of AMD. RESULTS: A high aMeDi score (score of 6-9) was significantly associated with a reduced risk of progression to advanced AMD after adjustment for demographic, behavioral, ocular, and genetic covariates (HR: 0.74; 95% CI: 0.61, 0.91; P-trend = 0.007). The aMeDi score was significantly associated with a lower risk of incident advanced AMD among subjects carrying the CFH Y402H nonrisk (T) allele (P-trend = 0.0004, P-interaction = 0.04). The aMeDi score was not associated with AMD among subjects who were homozygous for the risk (C) allele. CONCLUSION: Higher adherence to a Mediterranean diet was associated with reduced risk of progression to advanced AMD, which may be modified by genetic susceptibility. This trial was registered at clinicaltrials.gov as NCT00594672.
RCT Entities:
BACKGROUND: Adherence to a Mediterranean-type diet is linked to a lower risk of mortality and chronic disease, but the association with the progression of age-related macular degeneration (AMD) and genetic susceptibility is unknown. OBJECTIVE: We examined the association of adherence to the Mediterranean diet and genetic susceptibility with progression to advanced AMD. DESIGN: Among 2525 subjects in the AREDS (Age-Related Eye Disease Study), 1028 eyes progressed to advanced AMD over 13 y. Baseline data for demographic and behavioral covariates were collected by using questionnaires. Dietary data were collected from food-frequency questionnaires. The alternate Mediterranean diet (aMeDi) score (range: 0-9) was constructed from individual intakes of vegetables, fruit, legumes, whole grains, nuts, fish, red and processed meats, alcohol, and the ratio of monounsaturated to saturated fats. Ten genetic loci in 7 genes [complement factor H (CFH), age-related maculopathy susceptibility 2/high-temperature requirement A serine peptidase 1 (ARMS2/HTRA1), complement component 2 (C2), complement factor B (CFB), complement component 3 (C3), collagen type VIII α 1 (COL8A1), and RAD51 paralog B (RAD51B)] were examined. Survival analysis was used to assess individual eyes for associations between incident AMD and aMeDi score, as well as interaction effects between aMeDi score and genetic variation on risk of AMD. RESULTS: A high aMeDi score (score of 6-9) was significantly associated with a reduced risk of progression to advanced AMD after adjustment for demographic, behavioral, ocular, and genetic covariates (HR: 0.74; 95% CI: 0.61, 0.91; P-trend = 0.007). The aMeDi score was significantly associated with a lower risk of incident advanced AMD among subjects carrying the CFH Y402H nonrisk (T) allele (P-trend = 0.0004, P-interaction = 0.04). The aMeDi score was not associated with AMD among subjects who were homozygous for the risk (C) allele. CONCLUSION: Higher adherence to a Mediterranean diet was associated with reduced risk of progression to advanced AMD, which may be modified by genetic susceptibility. This trial was registered at clinicaltrials.gov as NCT00594672.
Authors: Fakir M Amirul Islam; Elaine W Chong; Allison M Hodge; Robyn H Guymer; Khin Zaw Aung; Galina A Makeyeva; Paul N Baird; John L Hopper; Dallas R English; Graham G Giles; Liubov D Robman Journal: Ophthalmology Date: 2014-02-20 Impact factor: 12.079
Authors: Michael L Klein; Peter J Francis; Bernard Rosner; Robyn Reynolds; Sara C Hamon; Dennis W Schultz; Jurg Ott; Johanna M Seddon Journal: Ophthalmology Date: 2008-06 Impact factor: 12.079
Authors: Eunyoung Cho; Susan E Hankinson; Bernard Rosner; Walter C Willett; Graham A Colditz Journal: Am J Clin Nutr Date: 2008-06 Impact factor: 7.045
Authors: Elizabeth C Schramm; Simon J Clark; Michael P Triebwasser; Soumya Raychaudhuri; Johanna Seddon; John P Atkinson Journal: Mol Immunol Date: 2014-07-15 Impact factor: 4.407
Authors: Shruti Dighe; Jiwei Zhao; Lyn Steffen; J A Mares; Stacy M Meuer; Barbara E K Klein; Ronald Klein; Amy E Millen Journal: Br J Ophthalmol Date: 2019-12-06 Impact factor: 4.638